At the Boston Atrial Fibrillation Symposium 2010, Professor John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it.
See the video: Interview with Professor John Camm at Boston Atrial Fibrillation Symposium 2010